Staar Surgical (STAA) Liabilities and Shareholders Equity (2010 - 2026)

Staar Surgical (STAA) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $451.1 million in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 1.37% year-over-year to $451.1 million; the trailing twelve-month figure through Apr 2026 stood at $1.8 billion (down 10.92% YoY), and the FY2026 full-year result was $451.7 million, down 11.35% from the prior year.
• Liabilities and Shareholders Equity for Q2 2026 stood at $451.1 million, roughly flat from $451.7 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $537.6 million in Q3 2024 and bottomed at $351.2 million in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $451.7 million (2026), against an average of $451.0 million.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity surged 32.12%; it then dropped 15.11% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $418.8 million in 2022, then climbed by 16.68% to $488.7 million in 2023, then rose by 4.26% to $509.5 million in 2024, then decreased by 10.43% to $456.4 million in 2025, then dropped by 1.15% to $451.1 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $451.1 million (Q2 2026), $451.7 million (Q1 2026), and $456.4 million (Q3 2025), per Business Quant data.

Peer Comparison